Table 4 |
||||
|
Inter-Group Analysis Comparing the Paired Treatment to Placebo Groups. |
||||
| Group OP vs. Group 0T |
Group NT vs. Group NP |
|||
|
|
||||
| T = 4 weeks |
T = 8 weeks |
T = 4 weeks |
T = 8 weeks |
|
|
|
||||
| Weight |
p < 0.01 |
p < 0.001 |
p < 0.05 |
p < 0.01 |
| BMI |
NS |
NS |
NS |
NS |
| Cholesterol |
p < 0.001 |
NS |
NS |
NS |
| HDL |
NS |
p < 0.001 |
p < 0.05 |
p < 0.05 |
| LDL |
NS |
p < 0.01 |
NS |
p < 0.01 |
| Triglycerides |
NS |
p < 0.001 |
p < 0.01 |
p < 0.01 |
| Systolic BP |
NS |
p < 0.05 |
p < 0.05 |
NS |
| Diastolic BP |
p < 0.05 |
p < 0.001 |
p < 0.05 |
p < 0.001 |
| Glucose |
p < 0.001 |
p < 0.001 |
NS |
NS |
|
|
||||
|
P-value comparisons are between overweight placebo (OP) and overweight treatment (OT) groups and between normal-weight placebo groups (NP) and normal-weight treatment (NT) groups at 4 and 8 weeks. NS = not significant. |
||||
|
Oben et al. Nutrition Journal 2008 7:16 doi:10.1186/1475-2891-7-16 |
||||
